Table 1. Review of the literature on MGCTs: patients who died of disease (DOD) or were living with disease (LWD).
| Reference | Age | Sex | Site | Treatment | Metastasis | Follow-up |
|---|---|---|---|---|---|---|
| Nielsen and Kiaer, 19893 | 67 | M | Knee (L) | AM, RT | B, ST | DOD (8 m) |
| Shinjo et al, 19934 | 72 | F | Hip (R) | EX, AM, CT | Lungs, viscera | DOD (5 m) |
| Bertoni et al, 19975 | 57 | M | Foot (R) | EX (2x), AM, RT | LN, ST, lungs | DOD ( year 9 m) |
| 74 | F | Knee (R) | EX (2x) | LN | DOD (3 years 5 m) | |
| 71 | F | Cheek (L) | EX (6x), RT | Lungs, brain | DOD (10 years 1 m) | |
| 12 | M | Thigh | EX | B, lungs | DOD (5 years) | |
| Kalil and Unni, 19986 | 21 | F | Ankle (R) | EX (3x), AM, RT | LN, lungs | DOD ( year) |
| Somerhausen and Fletcher, 20007 | 58 | F | Elbow | EX, AM | Lungs | DOD (2 years 11 m) |
| Bhadra et al, 20078 | 65 | M | Knee (L) | EX (2x), RT, CT | B, lungs | DOD (2 years 7 m) |
| Li et al., 20089 | 45 | M | Ankle | EX | B | DOD (10 m) |
| Imakiire et al., 201110 | 57 | F | Knee (L) | EX (3x), RT, CT | B | DOD (2 years 9 m) |
| Carstens and Howell, 197911 | 48 | F | Foot (R) | EX (2x), AM, RT | LN, ST | LWD (8 years 5 m) |
| Ushijima et al, 198612 | 59 | M | Knee (R) | EX (6x), AM, RT, CT, IT | LN, B, ST | LWD (4 years 4 m) |
| Li et al., 20089 | 39 | F | Forearm | AM, RT | LN, lungs | LWD ( year 5 m) |
| 68 | M | Supracubital | EX | LWD (3 years 7 m) |
DOD: n = 11, follow-up 5-121 months, mean 34 (32.2) months, median 31 months.
LWD: n = 4, follow-up 17-101 months, mean 53 (35.1) months, median 48 months.
Abbreviations: AM, amputation; CT, chemotherapy; EM, embolization; EX, excision; F, female; IT, immunotherapy; M, male; m, months; RT, radiotherapy; y, years.